Precision BioSciences (DTIL) Misses Q4 EPS by 222c
Precision BioSciences (NASDAQ: DTIL) reported Q4 EPS of ($2.22). Revenue for the quarter came in at $640 thousand.
For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.
